
Major Biotech Deal Shakes Up Allergy Treatment Market! Unprecedented Investment Announced
RAPT Therapeutics Secures Global Rights to Innovative Allergy Treatment RAPT Therapeutics has struck a monumental agreement that grants them exclusive worldwide rights, with the exception of certain Asian regions, to advance the development and commercialization of RPT904. This promising clinical-stage anti-immunoglobulin E